HOME >> MEDICINE >> NEWS
European commission grants "orphan" status for new acute myeloid leukaemia treatment

Wyeth-Ayerst Pharmaceuticals, the pharmaceutical division of American Home Products Corporation (NYSE:AHP),announced today that the European Commission has designated Mylotarg(gemtuzumab ozogamicin)as an "orphan medicinal product." The Commission decision follows a positive opinion adopted on 13 September 2000 by the Committee on Orphan Medicinal Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA).

"We anticipate that Mylotarg will become an important treatment option for European patients aged 60 and over with CD33-positive relapsed acute myeloid leukaemia (AML)," says L. Patrick Gage, Ph.D., President, Wyeth-Ayerst Research. "Its mechanism of action focuses on using antibody-antigen specificity to target delivery of potent chemotherapy to myeloid leukaemic cells. This compound represents the first product from Wyeth's promising oncology pipeline."

As a designated orphan medicinal product, Mylotarg will have access to the Commission's "centralised" procedure for assessment of the marketing authorisation application. Orphan medicinal products are intended to treat patients with rare life-threatening or very serious diseases for which no satisfactory method of treatment exists or where the product will be of significant benefit.

Orphan medicinal products do not automatically qualify for approval under "exceptional circumstances," but companies that sponsor orphan products receive incentives for bringing these products to the market and to the patient. Such incentives include the possibility of protocol assistance from the EMEA and fee reductions for all types of centralised marketing authorisation evaluation activities. If approved by the EMEA, Mylotarg would be the first product available in Europe from a new class of anticancer therapy known as "antibody-targeted chemotherapy." Mylotarg utilizes a patented linker technology with a novel potent anti-tumor antibiotic, calicheamicin.

Mylotarg is being develo
'"/>

Contact: Roseann Ward
roseann.ward@ketchumcomms.co.uk
44-0-207-465-8752
Ketchum
14-Nov-2000


Page: 1 2 3

Related medicine news :

1. ESC releases the first European Guidelines on Percutaneous Coronary Interventions (PCI)
2. The European Society of Cardiology launches Women at Heart
3. Use of potentially inappropriate medications among elderly common in some European countries
4. European folic acid policies are not effective enough
5. New European cancer figures for 2004 major efforts needed against the big four killers
6. Third of European cancer patients use complementary and alternative therapies
7. A new service from the European Patent Office
8. European study highlights persistent 3 decade increase in childhood cancer incidence
9. European nations urged to ratify international treaty on tobacco control
10. Increased investment in radiotherapy will improve cure rates for European cancer patients
11. ESA looking for more European women to volunteer for WISE bed-rest study in Toulouse next year

Post Your Comments:
(Date:7/22/2014)... July 22, 2014 The Restful Jaw ... the Restful Jaw ®. The FDA-registered external device ... while minimizing jaw pain, fatigue and soreness during dental ... treatment times when patients do not need to take ... The Restful Jaw is a vital solution in helping ...
(Date:7/22/2014)... University of the Pacific's Arthur A. ... of its state-of-the-art, $151 million campus this month. The ... San Francisco's South of Market (SoMa) district and houses ... patients will now be greeted by a wall of ... , Advanced Kiosks engineering team designed custom software to ...
(Date:7/22/2014)... HealthDay Reporter , MONDAY, July 21, 2014 (HealthDay ... high school may take fewer health risks than their peers ... of low-income Los Angeles teens, found that those who attended ... binge-drink, have multiple sex partners or take certain other health ... kids" being more likely to go to good schools, researchers ...
(Date:7/22/2014)... 21, 2014) Investigators at the Cedars-Sinai Samuel ... multistep investigational treatment for one of the most ... advanced pancreatic cancer. , Locally advanced pancreatic ... solid tumor, with a cumulative five-year survival rate ... disease. Surgery is rarely an option for patients ...
(Date:7/22/2014)... like electroconvulsive therapy (ECT) and transcranial magnetic stimulation ... depression. Like antidepressant medications, however, they typically have ... receive several weeks of regular ECT treatments before ... is an impetus to develop antidepressant treatments that ... stimulation (LFMS) is one such potential new treatment ...
Breaking Medicine News(10 mins):Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:iKiosks Are Gateway to Premier Dental Facility 2Health News:iKiosks Are Gateway to Premier Dental Facility 3Health News:Good Schools May Be Good for a Teen's Health, Too 2Health News:Good Schools May Be Good for a Teen's Health, Too 3Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 2Health News:Unique study focuses on combined treatment approach for locally advanced pancreatic cancer 3Health News:Low strength brain stimulation may be effective for depression 2
(Date:7/22/2014)... The number of people overdosing from opioid ... Twenty-three percent of the workforce has misused prescription painkillers, ... Health, making opioid use a serious threat to employee ... the correct dosage with a valid prescription, subtle impairment ... National Safety Council released a guide for employers, ...
(Date:7/22/2014)... TOTOWA, N.J. , July 22, 2014 ... Florida,s first 3-way Kidney Paired Donation ... landmark surgical procedures happened on July 9 at the ... Miami, Fla. ... pairs who are not compatible for kidney transplant with ...
(Date:7/22/2014)... Elekta (NSE:EKTAb) and Royal Philips ... Foundation Trust ( Manchester, UK ), a ... is to develop the clinical value of an integrated ... a system would, in principle, improve the practice of ... "The Christie was an essential participant in the ...
Breaking Medicine Technology:5 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4
Cached News: